Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-24-014594

EVP, Chief Technology Officer sold 2,305 shares at $95.00 ($218,975)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lingamneni Anila · EVP, Chief Technology Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-06 Sale : show line 1 in the form 10b5-1 −2,305 $95.00 $218,975 12,295 D
Open-market sales · 2,305 sh · avg $95.00 · $218,975
Loading xslF345X05/form4.xml…